163 related articles for article (PubMed ID: 9269965)
21. Low frequency of the p53 gene mutations in neuroblastoma.
Hosoi G; Hara J; Okamura T; Osugi Y; Ishihara S; Fukuzawa M; Okada A; Okada S; Tawa A
Cancer; 1994 Jun; 73(12):3087-93. PubMed ID: 8200007
[TBL] [Abstract][Full Text] [Related]
22. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations.
Bardeesy N; Beckwith JB; Pelletier J
Cancer Res; 1995 Jan; 55(2):215-9. PubMed ID: 7812946
[TBL] [Abstract][Full Text] [Related]
23. [Four new cases with WT1 gene mutations in Chinese patients with Wilms' tumor].
Jiang YP; Shen Y; Sun N; Wang H
Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):762-6. PubMed ID: 20021811
[TBL] [Abstract][Full Text] [Related]
24. Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma.
Felix CA; Kappel CC; Mitsudomi T; Nau MM; Tsokos M; Crouch GD; Nisen PD; Winick NJ; Helman LJ
Cancer Res; 1992 Apr; 52(8):2243-7. PubMed ID: 1559227
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas.
Watanabe H; Shimokado K; Asahara T; Dohi K; Niwa O
Jpn J Cancer Res; 1999 Jan; 90(1):40-7. PubMed ID: 10076563
[TBL] [Abstract][Full Text] [Related]
26. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors.
Waber PG; Chen J; Nisen PD
Cancer; 1993 Dec; 72(12):3732-8. PubMed ID: 8252491
[TBL] [Abstract][Full Text] [Related]
27. Absence of p53 gene mutations in primary neuroblastomas.
Vogan K; Bernstein M; Leclerc JM; Brisson L; Brossard J; Brodeur GM; Pelletier J; Gros P
Cancer Res; 1993 Nov; 53(21):5269-73. PubMed ID: 8221661
[TBL] [Abstract][Full Text] [Related]
28. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
29. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
[TBL] [Abstract][Full Text] [Related]
30. Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis.
Kuczyk MA; Serth J; Bokemeyer C; Jonassen J; Machtens S; Werner M; Jonas U
Cancer; 1996 Nov; 78(9):1958-66. PubMed ID: 8909317
[TBL] [Abstract][Full Text] [Related]
31. Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing.
Saed GM; Ladin D; Olson J; Han X; Hou Z; Fivenson D
Arch Dermatol; 1998 Aug; 134(8):963-7. PubMed ID: 9722726
[TBL] [Abstract][Full Text] [Related]
32. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
33. P53 mutations in Ewing's sarcoma.
Park YK; Chi SG; Kim YW; Park HR; Unni KK
Oncol Rep; 2001; 8(3):533-7. PubMed ID: 11295075
[TBL] [Abstract][Full Text] [Related]
34. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
35. Detection of TP53 gene mutations in human sarcomas.
Castresana JS; Rubio MP; Gómez L; Kreicbergs A; Zetterberg A; Barrios C
Eur J Cancer; 1995; 31A(5):735-8. PubMed ID: 7640047
[TBL] [Abstract][Full Text] [Related]
36. Codon 201(Gly) polymorphic type of the DCC gene is related to disseminated neuroblastoma.
Kong XT; Choi SH; Bessho F; Kobayashi M; Hanada R; Yamamoto K; Hayashi Y
Neoplasia; 2001; 3(4):267-72. PubMed ID: 11571626
[TBL] [Abstract][Full Text] [Related]
37. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
[TBL] [Abstract][Full Text] [Related]
38. Absence of germline and somatic p53 alterations in children with sporadic brain tumors.
Portwine C; Chilton-MacNeill S; Brown C; Sexsmith E; McLaughlin J; Malkin D
J Neurooncol; 2001 May; 52(3):227-35. PubMed ID: 11519852
[TBL] [Abstract][Full Text] [Related]
39. Infrequent mutation of the p53 gene in fibrous tumors of infancy and childhood.
Boman F; Peters J; Ragge N; Triche T
Diagn Mol Pathol; 1993 Mar; 2(1):14-22. PubMed ID: 8287221
[TBL] [Abstract][Full Text] [Related]
40. The relatively high frequency of p53 gene mutations in multiple and malignant phaeochromocytomas.
Yoshimoto T; Naruse M; Zeng Z; Nishikawa T; Kasajima T; Toma H; Yamamori S; Matsumoto H; Tanabe A; Naruse K; Demura H
J Endocrinol; 1998 Nov; 159(2):247-55. PubMed ID: 9795365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
